Jacobs Bruce N.'s Form 4 filing
Kymera Therapeutics, Inc. (KYMR) · filed Dec 3, 2021
- Accession no.
- 0000899243-21-046845
- Filed
- Dec 3, 2021
- Trade date
- Dec 3, 2021
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $535.6K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Jacobs Bruce N.CIK 0001821074 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 3, 2021 | Common Stock | MOption exerciseAcquired | +10,000 | $2.08 | +$20,800 | 27,514 | Direct | |
| Dec 3, 2021 | Common Stock | SSaleDisposed | −7,713 | $53.31F3 | −$411,180.03 | 19,801 | Direct | |
| Dec 3, 2021 | Common Stock | SSaleDisposed | −1,987 | $54.32F4 | −$107,933.84 | 17,814 | Direct | |
| Dec 3, 2021 | Common Stock | SSaleDisposed | −300 | $55.07F5 | −$16,521 | 17,514 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 3, 2021 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 189,899 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.91 to $53.88. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.92 to $54.74. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.96 to $55.12. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.